Evidence mapPaperPMID 20859683Full record

ArticleInternational urology and nephrology2011

Metformin-related lactic acidosis in patients with acute kidney injury.

Vassilios Devetzis, Ploumis Passadakis, Stelios Panagoutsos, Marios Theodoridis, Elias Thodis, Anastasia Georgoulidou, Vassilis Vargemezis

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vassilios DevetzisDivision of Nephrology, University Hospital of Alexandroupolis, Faculty of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece. vasdeve@yahoo.gr
Ploumis Passadakis
Stelios Panagoutsos
Marios Theodoridis
Elias Thodis
Anastasia Georgoulidou
Vassilis Vargemezis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetformin is nowadays considered as first-line therapy in individuals with non-insulin dependent diabetes mellitus (NIDDM). Metformin-related lactic acidosis (MALA) occurs more frequently after inappropriate use especially in patients with acute kidney injury (AKI) or chronic kidney disease (CKD). Thus, its prescription in these patients is contraindicated, while the role of dialysis is under evaluation.

methodsWe describe two cases of severe metformin-related lactic acidosis with underlying acute kidney injury, which were treated with dialysis.

resultsIn both cases, lactic acidosis occurred on a background of acute decline in renal function, possibly due to drug accumulation. It is interesting that metformin was contraindicated in one case.

conclusionLactic acidosis is a rare but potentially fatal adverse effect of metformin, particularly in patients with AKI, which should always be considered in clinical practice. Dialysis seems to contribute significantly to the management of this life-threatening condition and the improvement in outcome.

Indexed as

Acidosis, LacticAcute Kidney InjuryAgedContraindicationsDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMetforminMiddle AgedRenal DialysisHypoglycemic AgentsMetformin

Identifiers

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.